MORGAN STANLEY PLC/PUT/STRYKER CORP./300/0.1/20.06.25 Stock

Warrant

DE000ME0EXB1

Market Closed - Börse Stuttgart 02:24:03 2024-07-12 pm EDT
1.15 EUR -1.71% Intraday chart for MORGAN STANLEY PLC/PUT/STRYKER CORP./300/0.1/20.06.25
1 month+7.34%
3 months-17.61%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-12 1.15 -1.71%
24-07-11 1.17 -3.31%
24-07-10 1.21 +2.54%
24-07-09 1.18 -3.28%
24-07-08 1.22 -2.40%

Delayed Quote Börse Stuttgart

Last update July 12, 2024 at 02:24 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN ME0EXB
ISINDE000ME0EXB1
Date issued 2023-09-07
Strike 300 $
Maturity 2025-06-20 (343 Days)
Parity 10 : 1
Emission price 3.69
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.38
Lowest since issue 0.98
Spread 0.06
Spread %4.92%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
338.1 USD
Average target price
372.4 USD
Spread / Average Target
+10.16%
Consensus